DEVELOPMENT OF A POTENT BOMBESIN RECEPTOR ANTAGONIST WITH PROLONGED INVIVO INHIBITORY ACTIVITY ON BOMBESIN-STIMULATED AMYLASE AND PROTEIN RELEASE IN THE RAT

被引:50
|
作者
COY, DH
MUNGAN, Z
ROSSOWSKI, WJ
CHENG, BL
LIN, JT
MROZINSKI, JE
JENSEN, RT
机构
[1] TULANE UNIV, MED CTR, DEPT MED, GASTROENTEROL SECT, NEW ORLEANS, LA 70112 USA
[2] NIH, DIGEST DIS BRANCH, BETHESDA, MD 20892 USA
关键词
BOMBESIN ANTAGONISTS; BINDING; RAT ACINI; C6; CELLS; AMYLASE RELEASE;
D O I
10.1016/0196-9781(92)90186-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Of the various types of potent bombesin(Bn)/gastrin releasing peptide receptor antagonists that have been discovered, the desMet14-methyl ester peptides are devoid of residual agonist activity and are among the most potent in terms of in vitro receptor blockade and also in terms of their prolonged inhibition of bombesin-stimulated amylase and protein release in the mt. We have now examined the in vitro and in vivo properties of a new series of methyl ester analogues, [D-Phe6]Bn(6-13)OMe, [D-Phe6,D-Ala11]Bn(6-13)OMe, N(alpha)-propionyl-[D-Ala24]GRP(20-26)OMe, and [D-pentafluoro-Phe6,D-Ala11]Bn(6-13)OMe, which have an additional D-amino acid substituent and some highly lipophilic moieties at the N-terminus. All analogues were able to potently antagonize the ability of Bn to stimulate amylase release from rat acinar cells, with IC50 values of 2.4, 2.5, 0.6, and 1.3 nM, respectively. The four peptides were found to have binding affinities for these cells comparable to Bn itself, with K(i)s of 10.3, 2.8, 5.5, and 3.6 nM, respectively, but all had little or no affinity for neuromedin B receptors on murine C6 cells. Single bolus IV injections of these peptides were found to potently inhibit amylase and protein release caused by IV infusion of bombesin into the rat. Generally the peptides containing the D-Ala substituent were longer acting than [D-Phe 6]Bn(6-13)OMe, so that [D-PheD-Ala11]Bn(6-13)OMe and N(alpha)-propionyl-[D-Ala24]GRP(20-26)OMe displayed significant inhibitory effects for up to 1.5 h after administration. The most lipophilic analogue, [D-pentafluoro-Phe6,D-Ala11]Bn(6-13) OMe, however, was active for up to 4.5 h after injection and, at the same dose level as the other peptides, it had a fifteenfold longer duration of action. This analog appears to be a good candidate for clinical studies where prolonged blockade of endogenous bombesin-like peptides is desirable.
引用
收藏
页码:775 / 781
页数:7
相关论文
共 28 条